Literature DB >> 31740572

Genetic Testing for APOL1 Genetic Variants in Clinical Practice: Finally Starting to Arrive.

Jeffrey B Kopp1, Cheryl A Winkler2.   

Abstract

Entities:  

Keywords:  end stage kidney disease; genetic testing; genetic variants; genetic variation; kidney disease

Mesh：

Substances：

Year:  2019        PMID： 31740572      PMCID： PMC6946079          DOI： 10.2215/CJN.01810219

Source DB:  PubMed          Journal:  Clin J Am Soc Nephrol        ISSN： 1555-9041            Impact factor:   8.237


× No keyword cloud information.
  9 in total

1.  Association of trypanolytic ApoL1 variants with kidney disease in African Americans.

Authors:  Giulio Genovese; David J Friedman; Michael D Ross; Laurence Lecordier; Pierrick Uzureau; Barry I Freedman; Donald W Bowden; Carl D Langefeld; Taras K Oleksyk; Andrea L Uscinski Knob; Andrea J Bernhardy; Pamela J Hicks; George W Nelson; Benoit Vanhollebeke; Cheryl A Winkler; Jeffrey B Kopp; Etienne Pays; Martin R Pollak
Journal:  Science       Date:  2010-07-15       Impact factor: 47.728

2.  APOL1 risk variants, race, and progression of chronic kidney disease.

Authors:  Afshin Parsa; W H Linda Kao; Dawei Xie; Brad C Astor; Man Li; Chi-yuan Hsu; Harold I Feldman; Rulan S Parekh; John W Kusek; Tom H Greene; Jeffrey C Fink; Amanda H Anderson; Michael J Choi; Jackson T Wright; James P Lash; Barry I Freedman; Akinlolu Ojo; Cheryl A Winkler; Dominic S Raj; Jeffrey B Kopp; Jiang He; Nancy G Jensvold; Kaixiang Tao; Michael S Lipkowitz; Lawrence J Appel
Journal:  N Engl J Med       Date:  2013-11-09       Impact factor: 91.245

3.  You Are Just Now Telling Us About This? African American Perspectives of Testing for Genetic Susceptibility to Kidney Disease.

Authors:  Ebele M Umeukeje; Bessie A Young; Stephanie M Fullerton; Kerri Cavanaugh; Delia Owens; James G Wilson; Wylie Burke; Erika Blacksher
Journal:  J Am Soc Nephrol       Date:  2019-03-11       Impact factor: 10.121

4.  APOL1 Genotype and Renal Function of Black Living Donors.

Authors:  Mona D Doshi; Mariella Ortigosa-Goggins; Amit X Garg; Lihua Li; Emilio D Poggio; Cheryl A Winkler; Jeffrey B Kopp
Journal:  J Am Soc Nephrol       Date:  2018-01-16       Impact factor: 10.121

5.  APOL1 genetic variants in focal segmental glomerulosclerosis and HIV-associated nephropathy.

Authors:  Jeffrey B Kopp; George W Nelson; Karmini Sampath; Randall C Johnson; Giulio Genovese; Ping An; David Friedman; William Briggs; Richard Dart; Stephen Korbet; Michele H Mokrzycki; Paul L Kimmel; Sophie Limou; Tejinder S Ahuja; Jeffrey S Berns; Justyna Fryc; Eric E Simon; Michael C Smith; Howard Trachtman; Donna M Michel; Jeffrey R Schelling; David Vlahov; Martin Pollak; Cheryl A Winkler
Journal:  J Am Soc Nephrol       Date:  2011-10-13       Impact factor: 10.121

Review 6.  Clinical Genetic Testing for APOL1: Are we There Yet?

Authors:  Bessie A Young; Stephanie Malia Fullerton; James G Wilson; Kerri Cavanaugh; Erika Blacksher; Clarence Spigner; Jonathan Himmelfarb; Wylie Burke
Journal:  Semin Nephrol       Date:  2017-11       Impact factor: 5.299

7.  APOL1 Genotype and Kidney Transplantation Outcomes From Deceased African American Donors.

Authors:  Barry I Freedman; Stephen O Pastan; Ajay K Israni; David Schladt; Bruce A Julian; Michael D Gautreaux; Vera Hauptfeld; Robert A Bray; Howard M Gebel; Allan D Kirk; Robert S Gaston; Jeffrey Rogers; Alan C Farney; Giuseppe Orlando; Robert J Stratta; Sumit Mohan; Lijun Ma; Carl D Langefeld; Donald W Bowden; Pamela J Hicks; Nicholette D Palmer; Amudha Palanisamy; Amber M Reeves-Daniel; W Mark Brown; Jasmin Divers
Journal:  Transplantation       Date:  2016-01       Impact factor: 4.939

8.  Fetal-Not Maternal-APOL1 Genotype Associated with Risk for Preeclampsia in Those with African Ancestry.

Authors:  Kimberly J Reidy; Rebecca C Hjorten; Claire L Simpson; Avi Z Rosenberg; Stacy D Rosenblum; Csaba P Kovesdy; Frances A Tylavsky; Joseph Myrie; Bianca L Ruiz; Soulin Haque; Khyobeni Mozhui; George W Nelson; Victor A David; Xiaoping Yang; Masako Suzuki; Jack Jacob; Sandra E Reznik; Frederick J Kaskel; Jeffrey B Kopp; Cheryl A Winkler; Robert L Davis
Journal:  Am J Hum Genet       Date:  2018-08-30       Impact factor: 11.025

9.  Apolipoprotein L1 gene variants associate with hypertension-attributed nephropathy and the rate of kidney function decline in African Americans.

Authors:  Michael S Lipkowitz; Barry I Freedman; Carl D Langefeld; Mary E Comeau; Donald W Bowden; W H Linda Kao; Brad C Astor; Erwin P Bottinger; Sudha K Iyengar; Paul E Klotman; Richard G Freedman; Weijia Zhang; Rulan S Parekh; Michael J Choi; George W Nelson; Cheryl A Winkler; Jeffrey B Kopp
Journal:  Kidney Int       Date:  2012-07-25       Impact factor: 10.612
  9 in total
  6 in total

1.  APOL1 genotyping in kidney transplantation: to do or not to do, that is the question? (pro).

Authors:  Barry I Freedman; Emilio D Poggio
Journal:  Kidney Int       Date:  2021-07       Impact factor: 10.612

2.  Social Determinants of Health and Race Disparities in Kidney Transplant.

Authors:  Hannah Wesselman; Christopher Graham Ford; Yuridia Leyva; Xingyuan Li; Chung-Chou H Chang; Mary Amanda Dew; Kellee Kendall; Emilee Croswell; John R Pleis; Yue Harn Ng; Mark L Unruh; Ron Shapiro; Larissa Myaskovsky
Journal:  Clin J Am Soc Nephrol       Date:  2021-01-28       Impact factor: 8.237

3.  APOL1 at 10 years: progress and next steps.

Authors:  Barry I Freedman; Jeffrey B Kopp; Matthew G Sampson; Katalin Susztak
Journal:  Kidney Int       Date:  2021-03-29       Impact factor: 18.998

Review 4.  Association Between APOL1 Genotype and Kidney Diseases and Annual Kidney Function Change: A Systematic Review and Meta-Analysis of the Prospective Studies.

Authors:  Ram Jagannathan; Kanya Rajagopalan; Julien Hogan; Allyson Hart; Kenneth A Newell; Stephen O Pastan; Rachel E Patzer
Journal:  Int J Nephrol Renovasc Dis       Date:  2021-04-07

Review 5.  The evolving story of apolipoprotein L1 nephropathy: the end of the beginning.

Authors:  Parnaz Daneshpajouhnejad; Jeffrey B Kopp; Cheryl A Winkler; Avi Z Rosenberg
Journal:  Nat Rev Nephrol       Date:  2022-02-25       Impact factor: 42.439

6.  Multi-Institutional Implementation of Clinical Decision Support for APOL1, NAT2, and YEATS4 Genotyping in Antihypertensive Management.

Authors:  Thomas M Schneider; Michael T Eadon; Rhonda M Cooper-DeHoff; Kerri L Cavanaugh; Khoa A Nguyen; Meghan J Arwood; Emma M Tillman; Victoria M Pratt; Paul R Dexter; Allison B McCoy; Lori A Orlando; Stuart A Scott; Girish N Nadkarni; Carol R Horowitz; Joseph L Kannry
Journal:  J Pers Med       Date:  2021-05-27
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.